189 related articles for article (PubMed ID: 29499501)
1. Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease.
Butler T; Harvey P; Deshpande A; Tanzi E; Li Y; Tsui W; Silver C; Fischer E; Wang X; Chen J; Rusinek H; Pirraglia E; Osorio RS; Glodzik L; de Leon MJ
Neurobiol Aging; 2018 May; 65():201-205. PubMed ID: 29499501
[TBL] [Abstract][Full Text] [Related]
2. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
3. Association Between Smoking and Cholinergic Basal Forebrain Volume in Healthy Aging and Prodromal and Dementia Stages of Alzheimer's Disease.
Teipel S; Grothe MJ;
J Alzheimers Dis; 2016 Apr; 52(4):1443-51. PubMed ID: 27079707
[TBL] [Abstract][Full Text] [Related]
4. Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
Richter N; David LS; Grothe MJ; Teipel S; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Onur OA; Kukolja J
J Alzheimers Dis; 2022; 86(1):425-440. PubMed ID: 35068451
[TBL] [Abstract][Full Text] [Related]
5. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
[TBL] [Abstract][Full Text] [Related]
6. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.
Grothe MJ; Ewers M; Krause B; Heinsen H; Teipel SJ;
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S344-53. PubMed ID: 24418052
[TBL] [Abstract][Full Text] [Related]
7. Hippocampus and Basal Forebrain Volumetry for Dementia and Mild Cognitive Impairment Diagnosis: Could It Be Useful in Primary Care?
Teipel SJ; Keller F; Thyrian JR; Strohmaier U; Altiner A; Hoffmann W; Kilimann I
J Alzheimers Dis; 2017; 55(4):1379-1394. PubMed ID: 27834778
[TBL] [Abstract][Full Text] [Related]
8. Independent and additive contribution of white matter hyperintensities and Alzheimer's disease pathology to basal forebrain cholinergic system degeneration.
Kindler C; Upadhyay N; Bendella Z; Dorn F; Keil VC; Petzold GC
Neuroimage Clin; 2023; 39():103477. PubMed ID: 37478584
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2).
Rüb U; Farrag K; Seidel K; Brunt ER; Heinsen H; Bürk K; Melegh B; von Gall C; Auburger G; Bohl J; Korf HW; Hoche F; den Dunnen W
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):634-43. PubMed ID: 23363055
[TBL] [Abstract][Full Text] [Related]
10. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
11. Quantitative EEG and cholinergic basal forebrain atrophy in Parkinson's disease and mild cognitive impairment.
Rea RC; Berlot R; Martin SL; Craig CE; Holmes PS; Wright DJ; Bon J; Pirtošek Z; Ray NJ
Neurobiol Aging; 2021 Oct; 106():37-44. PubMed ID: 34233212
[TBL] [Abstract][Full Text] [Related]
12. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study.
Kilimann I; Grothe M; Heinsen H; Alho EJ; Grinberg L; Amaro E; Dos Santos GA; da Silva RE; Mitchell AJ; Frisoni GB; Bokde AL; Fellgiebel A; Filippi M; Hampel H; Klöppel S; Teipel SJ
J Alzheimers Dis; 2014; 40(3):687-700. PubMed ID: 24503619
[TBL] [Abstract][Full Text] [Related]
13. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis.
Mieling M; Meier H; Bunzeck N
Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861
[TBL] [Abstract][Full Text] [Related]
14. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD).
Scheef L; Grothe MJ; Koppara A; Daamen M; Boecker H; Biersack H; Schild HH; Wagner M; Teipel S; Jessen F
Neuroimage Clin; 2019; 21():101612. PubMed ID: 30555006
[TBL] [Abstract][Full Text] [Related]
15. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
16. The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.
Teipel SJ; Meindl T; Grinberg L; Grothe M; Cantero JL; Reiser MF; Möller HJ; Heinsen H; Hampel H
Hum Brain Mapp; 2011 Sep; 32(9):1349-62. PubMed ID: 20672311
[TBL] [Abstract][Full Text] [Related]
17. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.
Schmitz TW; Nathan Spreng R;
Nat Commun; 2016 Nov; 7():13249. PubMed ID: 27811848
[TBL] [Abstract][Full Text] [Related]
18. Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
Teipel SJ; Dyrba M; Ballarini T; Brosseron F; Bruno D; Buerger K; Cosma NC; Dechent P; Dobisch L; Düzel E; Ewers M; Fliessbach K; Haynes JD; Janowitz D; Kilimann I; Laske C; Maier F; Metzger CD; Munk MH; Peters O; Pomara N; Preis L; Priller J; Ramírez A; Roy N; Scheffler K; Schneider A; Schott BH; Spottke A; Spruth EJ; Wagner M; Wiltfang J; Jessen F; Heneka MT
J Alzheimers Dis; 2022; 85(3):1267-1282. PubMed ID: 34924387
[TBL] [Abstract][Full Text] [Related]
19. Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum.
Herdick M; Dyrba M; Fritz HJ; Altenstein S; Ballarini T; Brosseron F; Buerger K; Can Cetindag A; Dechent P; Dobisch L; Duezel E; Ertl-Wagner B; Fliessbach K; Dawn Freiesleben S; Frommann I; Glanz W; Dylan Haynes J; Heneka MT; Janowitz D; Kilimann I; Laske C; Metzger CD; Munk MH; Peters O; Priller J; Roy N; Scheffler K; Schneider A; Spottke A; Jakob Spruth E; Tscheuschler M; Vukovich R; Wiltfang J; Jessen F; Teipel S; Grothe MJ
Neuroimage Clin; 2020; 28():102495. PubMed ID: 33395986
[TBL] [Abstract][Full Text] [Related]
20. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
